Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Biol Regul Homeost Agents ; 29(2): 493-500, 2015.
Article in English | MEDLINE | ID: mdl-26122242

ABSTRACT

It is already known that the conditions of increased oxidative stress are associated to a greater susceptibility to vascular malformations including cerebral cavernous malformations (CCMs). These are vascular lesions of the CNS characterized by abnormally enlarged capillary cavities that can occur sporadically or as a familial autosomal dominant condition with incomplete penetrance and variable clinical expression attributable to mutations in three different genes: CCM1(Krit1), CCM2 (MGC4607) and CCM3 (PDCD10). Polymorphisms in the genes encoding for enzymes involved in the antioxidant systems such as glyoxalase I (GLO I) and paraoxonase I (PON I) could influence individual susceptibility to the vascular malformations. A single nucleotide polymorphism was identified in the exon 4 of GLO 1 gene that causes an amino acid substitution of Ala for Glu (Ala111Glu). Two common polymorphisms have been described in the coding region of PON1, which lead to glutamine → arginine substitution at 192 (Q192R) and a leucine → methionine substitution at 55 (L55M). The polymorphisms were characterized in 59 patients without mutations in the CCM genes versus 213 healthy controls by PCR/RFLP methods using DNA from lymphocytes. We found that the frequency of patients carrying the GLO1 A/E genotype among the case group (56%) was four-fold higher than among the controls (14.1%). In the cohort of CCM patients, an increase in the frequency of PON192 Q/R genotype was observed (39% in the CCM group versus 3.7% in the healthy controls). Similarly, an increase was observed in the proportion of individuals with the genotype R/R in the disease group (5%) in respect to the normal healthy cohort (0.5%). Finally, the frequency of the PON55 heterozygotes L/M genotype was 29% in patients with CCMs and 4% in the healthy controls. The same trend was observed in PON55 homozygous M/M genotype frequency (CCMs 20% vs controls 10%). The present study aimed to investigate the possible association of GLO1 A111E, PON1 Q192R and L55M polymorphisms with the risk of CCMs. We found that individuals with the GLO1 A /E genotype, PON192/QR-RR genotypes and PON55/LM-MM genotypes had a significantly higher risk of CCMs compared with the other genotypes. However, because CCM is a heterogeneous disease, other additional factors might be involved in the initiation and progression of CCM disease.


Subject(s)
Hemangioma, Cavernous, Central Nervous System/genetics , Lactoylglutathione Lyase/genetics , Polymorphism, Single Nucleotide , Adult , Age of Onset , Aged , Amino Acid Substitution , DNA Mutational Analysis , Female , Gene Frequency , Genotype , Haplotypes/genetics , Hemangioma, Cavernous, Central Nervous System/epidemiology , Humans , Italy/epidemiology , Lymphocytes/chemistry , Male , Middle Aged , Pilot Projects , Young Adult
2.
Eur J Gynaecol Oncol ; 3(2): 101-6, 1982.
Article in English | MEDLINE | ID: mdl-6299742

ABSTRACT

The authors studied the HSV-TAA (Herpes Simplex Virus Tumor Associated Antigen) in patients affected by female genitale tract tumors, using the immunoenzymatic assay (ELISA). They found a positive frequence of 65% in sera of patients affected by uterine cervical carcinoma and of the 80% in sera of patients affected by vulvar carcinoma. The authors suggest that this enzymatic method has a real value and propose its use in the early diagnosis of the female genital tract neoplasms.


Subject(s)
Antigens, Neoplasm/analysis , Antigens, Viral/analysis , Simplexvirus/immunology , Uterine Cervical Neoplasms/analysis , Vulvar Neoplasms/analysis , Female , Genital Neoplasms, Female/diagnosis , Genital Neoplasms, Female/immunology , Humans , Immunoenzyme Techniques , Uterine Cervical Neoplasms/immunology , Vulvar Neoplasms/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...